Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)
Clinical trial NCT00147901 · COMPLETED
Trial details
- NCT number
- NCT00147901
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2008-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.